Navigation Links
P.F.S. Plantar Fasciitis Splint

ProductsP.F.S. Plantar Fasciitis Splint
Company Bird & Cronin Inc.
Item P.F.S. Plantar Fasciitis Splint
Features 
  • Designed to provide relief from pain and discomfort of plantar fasciitis and Achilles tendonitis
  • Allows the patient to apply consistent stretch to the plantar fascia by holding the foot in gentle dorsiflexion
  • Lightweight design for patient comfort while sleeping
  • Fits either left or right foot
  • Description Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and Internationally through various distribution sources.
    Info Bird & Cronin Inc.
    Customer Service: (800) 328-1095
    Web site: http://www.birdcronin.com/

    Related medicine products :

    1. Bledsoe Nite N Day Plantar Fasciitis Orthosis
    2. Night Stretch Plantar Fasciitis Splint
    3. Ultra 90 Fixed Plantar Fasciitis Splint
    4. Plantar Fasciitis Night Splint
    5. Utility & Splinter Forceps #H
    6. AlAliMed® Footdrop Night Splint™
    7. XR Cubital Tunnel Elbow Splint
    8. Crestone Night Splint
    9. Extended Length Humeral Splint
    10. Humeral Splint
    11. Oval-8™ Ring Splints
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products:
    (Date:4/24/2017)... ... 2017 , ... Donna Parker, L. Ac. reads all sorts of books on ... to be very practical. She wanted to write a guide/workbook that would give readers ... It prompted her in writing “ A Clear Path to a Vibrant Life : ...
    (Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
    (Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is ... the process rendered in my Art and Music. These are created as Metaphysical Transformations ... the boundary of mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , ...
    (Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
    (Date:4/21/2017)... ... April 21, 2017 , ... Contrary ... that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright ... people involved in violence in the United States. The study, Trends in ...
    Breaking Medicine News(10 mins):
    (Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
    (Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
    (Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
    Breaking Medicine Technology: